First cannabis-based product under MCAP to be available from next month
Epilepsy is one of the main conditions people are seeking cannabis treatment for in Ireland. File photo: iStock
The first cannabis-based product to be made available through the Medical Cannabis Access Programme will be accessible from mid-October.
The product is CannEpil oral solution which contains both tetrahydrocannabinol (THC) a psychoactive derivative of cannabis, and cannabidiol (CBD).
